Twist Bioscience Corporation Common Stock (TWST) — Analysis Summary
Twist Bioscience Corporation Common Stock (TWST) has a market cap of $5.03B with year-over-year revenue growth of +20.3%. Net margin stands at -20.6%. The stock trades at a P/E ratio of -61.9.
Key Takeaways
- Revenue changed +20.3% year-over-year
- Net margin of -20.6%
- P/E ratio of -61.9
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, TWST posted revenue growth of +20.3% and trades at a P/E of -61.9.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.